When a room of physicians at ASH 2024 was asked whether they had prescribed a gene therapy in a commercial context, only a ...

Indian scientists successfully use gene therapy to treat severe haemophilia A, a rare hereditary condition with promising ...

Haemophilia is a severe bleeding disorder caused by the deficiency of clotting Factor VIII, leading to spontaneous internal ...

There are approximately 950 registered haemophilia patients in Mumbai, and the shortage of treatments has become critical.

In a significant medical feat, Indian scientists have developed the first-in-human gene therapy using lentiviral vectors for ...

The 2nd Annual General Meeting of the Biotechnology Research and Innovation Council (BRIC) Society was held today under the ...

Haemophilia patients led a deputation to the medical superintendent of the Burdwan Medical College and Hospital today as they ...

Health minister Dzulkefly Ahmad says they are committed to ensuring a sufficient supply of drugs to treat those with this ...

BHUBANESWAR: In a significant medical breakthrough, India's first human gene therapy with a lentiviral vector for severe haemophilia-A has been found to be succ ...

More than RM85mil has been spent to procure 18 types of haemophilia treatment medication between Jan 1 and Oct 30 of this ...

HIBISCUS phase 2 data evaluating the safety profile and efficacy of etavopivat in adult and adolescent patients with sickle ...

Pfizer’s anti-TFPI antibody marstacimab has been approved by the FDA to treat haemophilia, becoming the pharma group’s second new therapy for the blood disorder this year. Marstacimab will be ...